Applied Molecular Transport Inc.

The momentum for this stock is not very good. Applied Molecular Transport Inc. is not very popular among insiders. Applied Molecular Transport Inc. is a mediocre stock to choose.

News

Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.

Business Wire Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (Cyclo Therapeutics or the Company), a clinical stage biotechnology company focused on developing transformative therapies for rare and neurological diseases...\n more…

Applied Molecular Transport (NASDAQ:AMTI) Shares Up 8.4%

Zolmax Applied Molecular Transport Inc. (NASDAQ:AMTI Get Free Report)s share price shot up 8.4% during trading on Thursday . The company traded as high as $0.30 and last traded at $0.30...\n more…

Applied Molecular Transport Inc. (NASDAQ:AMTI) Director Tahir Ph.D. Mahmood Sells 286,320 Shares

Zolmax Applied Molecular Transport Inc. (NASDAQ:AMTI Get Free Report) Director Tahir Ph.D. Mahmood sold 286,320 shares of the companys stock in a transaction dated Wednesday, November 22nd...\n more…

Insider Selling: Applied Molecular Transport Inc. (NASDAQ:AMTI) CEO Sells 110,802 Shares of Stock

Ticker Report Applied Molecular Transport Inc. (NASDAQ:AMTI Get Free Report) CEO Shawn Cross sold 110,802 shares of the companys stock in a transaction dated Wednesday, November 22nd. The shares...\n more…

Shawn Cross Sells 90,447 Shares of Applied Molecular Transport Inc. (NASDAQ:AMTI) Stock

Ticker Report Applied Molecular Transport Inc. (NASDAQ:AMTI Get Free Report) CEO Shawn Cross sold 90,447 shares of the businesss stock in a transaction on Wednesday, November 15th. The shares were...\n more…

Applied Molecular Transport Reports Third Quarter 2023 Financial Results

Globe Newswire Company Entered into Definitive Merger Agreement with Cyclo Therapeutics Cash and Cash Equivalents of $18.1 million, as of September 30, 2023 SOUTH SAN FRANCISCO, Calif., Nov. 09, 2023 (GLOBE...\n more…